NEVVI Medicare utilization intelligence

Geography — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg (J7614) in Medicare, the United States

Geography · J7614 · National · CY2024 Geography: 19 states
The full market analysis — how large this market is in Medicare dollars, who holds most of the volume, and how it is moving. See the full market analysis → or start a trial
Where J7614 is billed · every state market

Every state market that bills this code, by services, each linked to its own market page.

← Back to the market overview